Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:Richard Muscat: Difference between revisions - WikiTrademarks Jump to content

Category:Richard Muscat: Difference between revisions

From WikiTrademarks
Updating Category:Richard_Muscat
 
Updating Category:Richard_Muscat
 
Line 2: Line 2:


=== Executive Summary ===
=== Executive Summary ===
Richard Muscat is an inventor who has filed 4 patents. Their primary areas of innovation include No explanation available (4 patents), No explanation available (4 patents), No explanation available (4 patents), and they have worked with companies such as University of Washington (4 patents). Their most frequent collaborators include [[Category:Georg Seelig of Seattle WA (US)|Georg Seelig of Seattle WA (US)]] (4 collaborations), [[Category:Alexander B. Rosenberg of Seattle WA (US)|Alexander B. Rosenberg of Seattle WA (US)]] (4 collaborations).
Richard Muscat is an inventor who has filed 4 patents. Their primary areas of innovation include Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay  ( (4 patents), {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags} (4 patents), Ligating adaptors (4 patents), and they have worked with companies such as University of Washington (4 patents). Their most frequent collaborators include [[Category:Georg Seelig of Seattle WA (US)|Georg Seelig of Seattle WA (US)]] (4 collaborations), [[Category:Alexander B. Rosenberg of Seattle WA (US)|Alexander B. Rosenberg of Seattle WA (US)]] (4 collaborations).


=== Patent Filing Activity ===
=== Patent Filing Activity ===
Line 11: Line 11:


==== List of Technology Areas ====
==== List of Technology Areas ====
* [[:Category:CPC_C12Q1/6806|C12Q1/6806]] (No explanation available): 4 patents
* [[:Category:CPC_C12Q1/6806|C12Q1/6806]] (Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay  (): 4 patents
* [[:Category:CPC_C12N15/1065|C12N15/1065]] (No explanation available): 4 patents
* [[:Category:CPC_C12N15/1065|C12N15/1065]] ({Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}): 4 patents
* [[:Category:CPC_C12Q1/6855|C12Q1/6855]] (No explanation available): 4 patents
* [[:Category:CPC_C12Q1/6855|C12Q1/6855]] (Ligating adaptors): 4 patents


=== Companies ===
=== Companies ===

Latest revision as of 16:54, 19 July 2024

Richard Muscat

Executive Summary

Richard Muscat is an inventor who has filed 4 patents. Their primary areas of innovation include Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay ( (4 patents), {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags} (4 patents), Ligating adaptors (4 patents), and they have worked with companies such as University of Washington (4 patents). Their most frequent collaborators include (4 collaborations), (4 collaborations).

Patent Filing Activity

File:Richard Muscat Monthly Patent Applications.png

Technology Areas

File:Richard Muscat Top Technology Areas.png

List of Technology Areas

  • C12Q1/6806 (Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (): 4 patents
  • C12N15/1065 ({Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}): 4 patents
  • C12Q1/6855 (Ligating adaptors): 4 patents

Companies

File:Richard Muscat Top Companies.png

List of Companies

  • University of Washington: 4 patents

Collaborators

Subcategories

This category has the following 3 subcategories, out of 3 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.